Qiming U.S. Ventures Management as of Sept. 30, 2022
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ventyx Biosciences (VTYX) | 37.8 | $26M | 746k | 34.91 | |
| Icosavax | 16.1 | $11M | 3.5M | 3.16 | |
| Hillevax (HLVX) | 13.9 | $9.6M | 559k | 17.09 | |
| Talaris Therapeutics | 11.2 | $7.7M | 2.9M | 2.63 | |
| Kezar Life Sciences (KZR) | 10.4 | $7.1M | 829k | 8.61 | |
| Jasper Therapeutics | 6.7 | $4.6M | 5.9M | 0.79 | |
| Elevation Oncology (ELEV) | 3.9 | $2.7M | 2.4M | 1.13 |
